WHEAT RIDGE, CO / ACCESS Newswire / March 28, 2025 / Lifeloc Technologies, Inc. (OTC PINK:LCTC), a global leader in the ...

LONDON, GB / ACCESS Newswire / March 28, 2025 / Black Book Market Research, a leading independent and unbiased technology ...

Eli Lilly and Company (LLY) has expanded its LillyDirect digital healthcare platform to offer connections to independent ...

BETHESDA, MARYLAND / ACCESS Newswire / March 28, 2025 / Solaxa Inc., a biopharmaceutical public benefit corporation focused on rare neurological conditions, has announced plans to conduct a ...

Curium Pharma (“Curium”), a world leader in nuclear medicine, is pleased to announce the completion of its acquisition of Eczacıbaşı-Monrol Nuclear Products Co. (Monrol), a leading nuclear medicine ...

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced it has acquired a majority interest in Aurion Biotech, Inc., a clinical-stage company ...

Abbott (NYSE: ABT) today announced it has received CE Mark in Europe for the Volt™ PFA System to treat patients battling atrial fibrillation (AFib). With the earlier-than-expected CE Mark, Abbott has ...

SALT LAKE CITY, UTAH / ACCESS Newswire / March 28, 2025 / PointClickCare, a leading healthcare technology platform enabling meaningful collaboration across the care continuum, and VistaRx, a ...

The Global Nutraceuticals Market valued at $416 billion (2021), is expected to witness a growth rate of 8-9% in the next five years.Need for dietary and food supplements stems from a sedentary ...

Molecure achieved key milestones in the development of its innovative therapies in 2024 and plans to accelerate research and development in its most advanced clinical programs: OATD-01 and OATD-02. A ...

Find out the change in Physiotherapy DUBAI, UAE / ACCESS Newswire / March 28, 2025 / Since the immerge of healthcare innovation and technology, there has been significant change that's complementing ...

Moderna, Inc. (NASDAQ:MRNA) today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK has granted marketing authorization for mRESVIA (mRNA-1345), indicated for ...